These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19699754)
1. Behavioural characterisation of the effects of acute and repeated administration of GBR 12909 in rats: further evaluation of a potential model of ADHD. Hewitt KN; Marsden CA; Hollis CP; Fone KC Neuropharmacology; 2009 Dec; 57(7-8):678-86. PubMed ID: 19699754 [TBL] [Abstract][Full Text] [Related]
2. Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder. Hiraide S; Ueno K; Yamaguchi T; Matsumoto M; Yanagawa Y; Yoshioka M; Togashi H Pharmacol Biochem Behav; 2013 Apr; 105():89-97. PubMed ID: 23380523 [TBL] [Abstract][Full Text] [Related]
3. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696 [TBL] [Abstract][Full Text] [Related]
4. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats. Howland JG; Hannesson DK; Phillips AG Eur J Neurosci; 2004 Nov; 20(10):2639-48. PubMed ID: 15548207 [TBL] [Abstract][Full Text] [Related]
5. Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD). Pires VA; Pamplona FA; Pandolfo P; Prediger RD; Takahashi RN Behav Brain Res; 2010 Dec; 215(1):39-44. PubMed ID: 20600342 [TBL] [Abstract][Full Text] [Related]
6. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336 [TBL] [Abstract][Full Text] [Related]
7. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523 [TBL] [Abstract][Full Text] [Related]
8. Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism. Kinkead B; Selz KA; Owens MJ; Mandell AJ J Neurosci Methods; 2006 Feb; 151(1):68-81. PubMed ID: 16423408 [TBL] [Abstract][Full Text] [Related]
9. Neurobiology of animal models of attention-deficit hyperactivity disorder. Russell VA J Neurosci Methods; 2007 Apr; 161(2):185-98. PubMed ID: 17275916 [TBL] [Abstract][Full Text] [Related]
10. Rodent models of attention-deficit/hyperactivity disorder. Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994 [TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model. Muneoka K; Kuwagata M; Iwata M; Shirayama Y; Ogawa T; Takigawa M Congenit Anom (Kyoto); 2006 Sep; 46(3):155-9. PubMed ID: 16922923 [TBL] [Abstract][Full Text] [Related]
12. Reversal of prenatal diazepam-induced deficit in a spatial-object learning task by brief, periodic maternal separation in adult rats. Cannizzaro E; Martire M; Gagliano M; Plescia F; La Barbera M; Mantia G; Mineo A; Cannizzaro G; Cannizzaro C Behav Brain Res; 2005 Jun; 161(2):320-30. PubMed ID: 15922060 [TBL] [Abstract][Full Text] [Related]
13. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder. Hewitt KN; Shah YB; Prior MJ; Morris PG; Hollis CP; Fone KC; Marsden CA Psychopharmacology (Berl); 2005 Aug; 180(4):716-23. PubMed ID: 15864553 [TBL] [Abstract][Full Text] [Related]
14. Amphetamine sensitization in rats as an animal model of schizophrenia. Peleg-Raibstein D; Knuesel I; Feldon J Behav Brain Res; 2008 Aug; 191(2):190-201. PubMed ID: 18486243 [TBL] [Abstract][Full Text] [Related]
15. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Hawk LW; Yartz AR; Pelham WE; Lock TM Psychopharmacology (Berl); 2003 Jan; 165(2):118-27. PubMed ID: 12417963 [TBL] [Abstract][Full Text] [Related]
16. Individual differences in cocaine-induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens. Sabeti J; Gerhardt GA; Zahniser NR J Pharmacol Exp Ther; 2003 Apr; 305(1):180-90. PubMed ID: 12649367 [TBL] [Abstract][Full Text] [Related]
17. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder]. Díaz-Heijtz R; Mulas F; Forssberg H Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214 [TBL] [Abstract][Full Text] [Related]
18. Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHD. Ruocco LA; de Souza Silva MA; Topic B; Mattern C; Huston JP; Sadile AG Eur Neuropsychopharmacol; 2009 Oct; 19(10):693-701. PubMed ID: 19328660 [TBL] [Abstract][Full Text] [Related]
19. Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications. Reichel CM; Linkugel JD; Bevins RA Exp Clin Psychopharmacol; 2007 Oct; 15(5):501-9. PubMed ID: 17924784 [TBL] [Abstract][Full Text] [Related]
20. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]